Moderna to file for EUA of COVID-19 shot for very young kids by end-April

Moderna plans to submit an application to the US health regulator for emergency use authorisation of its COVID-19 vaccine among kids between the ages of six months to five years by end of the month, a company spokesperson said on Wednesday .

The Omicron variant was predominant during Moderna's pediatric trial, and the drugmaker said two doses were around 38 per cent effective in preventing infections in two to five-year-olds and 44 per cent effective for children aged six months to under two years. Last week, Pfizer and BioNTech said a third dose of the COVID-19 vaccine produced significant protection against the Omicron variant in healthy children from ages five to 11.

Earlier this year, the US Food & Drug Administration authorised a third dose of the Pfizer-BioNTech vaccine for children ages 12 to 15 and those aged five through 11 who are immunocompromised.

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna says trial results suggest redesigned Covid-19 vaccines can better protect against variants
Source: STForeignDesk - 🏆 4. / 71 Read more »

HSA grants interim authorisation for oral Covid-19 drug molnupiravirSINGAPORE — The Health Sciences Authority (HSA) on Tuesday (April 19) granted interim authorisation for the use of molnupiravir as an oral treatment for mild to moderate Covid-19.
Source: TODAYonline - 🏆 1. / 99 Read more »

Australia's New South Wales, Victoria states end isolation period for Covid-19 close contacts
Source: STForeignDesk - 🏆 4. / 71 Read more »

Planning a holiday? Here’s your guide to travel rules around the world | The Straits TimesPlanning a holiday? Check our travel planner for Covid19 rules at every destination
Source: straits_times - 🏆 5. / 69 Read more »

China's Xi sticks with Covid-19 stance despite anger, economic headwindsBEIJING - For many leaders, mounting public anger and a rapidly worsening economic outlook would be cause for worry and a policy rethink. But Chinese President Xi Jinping, who doubtless would prefer smoother sailing in the run-up to a third leadership term, is doubling down on a signature 'dynamic zero' Covid-19 policy that has been increasingly tested by the more...
Source: asiaonecom - 🏆 10. / 59 Read more »